E Fund Management Co., Ltd. Arcellx, Inc. Transaction History
E Fund Management Co., Ltd.
- $2.07 Billion
- Q1 2025
A detailed history of E Fund Management Co., Ltd. transactions in Arcellx, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 5,468 shares of ACLX stock, worth $382,705. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,468
Previous 5,049
8.3%
Holding current value
$382,705
Previous $384,000
6.77%
% of portfolio
0.02%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding ACLX
# of Institutions
211Shares Held
48.7MCall Options Held
764KPut Options Held
296K-
Paradigm Biocapital Advisors LP New York, NY4.49MShares$314 Million15.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.99MShares$279 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$262 Million23.3% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$246 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.04MShares$213 Million4.14% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.07B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...